The reproductive health devices market includes Endometrial Ablation devices, Female Sterilization devices, Reversible Contraceptive devices and Assisted Reproductive Technology devices. Reversible contraceptive devices are used as birth control to prevent unwanted pregnancy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reversible contraceptive devices devices market, including market shares of different players within Finland. Buy the latest report here.
In 2021, GlobalData’s Market Model methodology determined that the leading player in the reversible contraceptive devices market in Finland was Bayer followed by Merck, HLL Lifecare, Shanghai Dahua Pharmaceuticals, Allergan Aesthetics, CooperSurgical, Kessel Marketing & Vertriebs, Meril Life Sciences and Pregna International.
Reversible Contraceptive Devices are inserted or implanted into women of child-bearing age, often for long periods of time. This includes Intrauterine Devices (IUDs), Diaphragms and Implants.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the reversible contraceptive devices devices market within Finland was expected to be over $3m in 2021.
For the latest complete market share analysis of reversible contraceptive devices device market in Finland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.